Welcome to the NeoMega36 Webinar®ARA and DHA Supplementation: Pioneers & First Experiences in European NICUs – Insights from German and Greek Hospitals By Neobiomics, Karolinska Institutet Science Park!We are excited to invite you to our exclusive webinar, where leading neonatologists will discuss their clinical experiences with NeoMega36®. An innovative solution with arachidonic acid (ARA) and docosahexaenoic acid (DHA), supporting the Normal Vision Development in Extremely Preterm infants.CLICK HERE TO REGISTERWEBINAR INFORMATION DATE and TIME: 20 May, 15.00 CET DURATION: 50 minutesIN THIS WEBINAR, THE SPEAKERS WILL COVER: • Short introduction about NeoMega36® by Dr. Stefan Johansson • First-hand experiences using NeoMega36® at SRH Zentralklinikum Hospital Suhl, Germany - Dr. med. Sebastian Horn, Head of Paediatric Department • Upcoming implementation study with NeoMega36® at Papageorgiou Hospital, Greece - Dr. Maria Lithoxopoulou, Neonatologist and Assistant Professor in Neonatology & Paediatrics • Discussion of key clinical outcomes and best practicesCLICK HERE TO REGISTER**Seats are limited**, so don’t miss out on this opportunityWe look forward to your participation! Best regards, Neobiomics Team(Note: This event is exclusively for healthcare professionals and official partners.)

Dear Colleagues,A collaborative team of Spanish and Italian researchers specialized in neonatal pharmacology, infectious diseases, and vascular access has developed a survey focused on managing vascular access devices across Europe. Some team members are affiliated with the European Society of Pediatric Research (ESPR) and the European Society of Pediatric and Neonatal Intensive Care (ESPNIC). The survey aims to better understand how neonatologists manage vascular access devices in European Neonatal Intensive Care Units (NICUs) during clinical practice. Additionally, we strive to explore the potential adherence to local or international guidelines.We recommend that the NICU team leader or a senior neonatologist from the unit participate in this survey.The name of the Neonatal Unit is requested solely to mitigate the risk of response duplication and will be eliminated before data processing. No individual or institution will receive information regarding the specific responses provided.The implementation of the survey will require approximately 20 minutes. Main researcher contacts:Giacomo Cavallaro: giacomo.cavallaro@policlinico.mi.it; and Felipe Garrido: fgarridom@unav.es.  Should you have any inquiries or remarks, please do not hesitate to contact us via email: Andrea Ronchi: andrea.ronchi@policlinico.mi.it; Roberto Raschetti: roberto.raschetti@policlinico.mi.it; Carmen Rodriguez: carmen.rodriguez@asst-spedalicivili.it; Francesco Risso: francesco.risso@asst-spedalicivili.it; Nunzia Decembrino: n.decembrino@policlinico.unict.it; Carlo Pietrasanta: carlo.pietrasanta@unimi.it; Genny Raffaeli: genny.raffaeli@policlinico.mi.it; Antonio Perez Iranzo: antonio.perez.iranzo@gmail.com; Silvia Garrido: sgarridoe@unav.es; Daniela Svedin Figo: dsvedinfigo@alumni.unav.es; Mónica Riaza Gómez: mriazagomez@unav.es; Roberto Ortiz Movilla: rortizmovilla@gmail.com.We thank you for your interest in participating in our study. The Research Ethics Committee of the University of Navarra has approved this study. Before deciding on participation in this survey, please ensure you understand the purpose of the research, what your involvement will entail, and how your information will be used.What is the purpose of the study?The study aims to gather information about managing vascular access for newborns in neonatal units at the European level.How will the study be conducted?We will use a questionnaire developed and validated by the researchers using the Delphi methodology.Your participation in this study is entirely voluntary. Once you complete the questionnaire, please note that your responses will be anonymous and cannot be deleted.Who can participate?The study is open to all healthcare professionals caring for newborns in European neonatal units. You can participate by accessing the questionnaire through the various dissemination channels.Your role in this study is limited to answering the questionnaire. We do not collect any identifiable information, such as your IP address.Financial Compensation: There is no financial compensation for participation in this study.Funding: This study does not have any external funding.The project has been approved by the ethics committee of the University of Navarra: Proyecto 2025.088, Aprobado CEI Unav: Acta 10.04.2025.I attach the link and QR code of our surveyhttps://it.surveymonkey.com/r/K9WDJXX

The American Academy of Pediatrics, AAP calls NICU staff, researchers, families and all others policy makers, kicking off the #BabiesNeedScience campaign on April 25!While the initiative seems to originate in the current US context, we all know that science is essential for improving public health of infants world wide.As an organisation connecting health care professionals in a global network, we share the values behind this campaign. It may seem like an obvious position that science is instrumental for evidence-based practices in NICUs. However, we experience a time in history where high-pitched opinions want to change the narrative about meaningful public health strategies to reduce the disease burden of newborns.Therefore, the #BabiesNeedScience campaign is a timely initiative that we fully support. We want to encourage all 99nicu members to join this campaign, by speaking out why #BabiesNeedScience, on this web site and in your social media channels. Support and follow AAPs example.https://www.instagram.com/p/DIsjikrxc4h/

Test your diagnostic and management skills with our newest quiz: "Critical Care Challenge: Unexpected Complications in a Premature Infant" - can you navigate the complex clinical course of a preterm neonate with multiple emerging complications?

I wanted to share a few Journal Clubs that @EBNEO did a few years back, great educational videos that are published on their Youtube account.I suggest that one watches them in the order as embedded below!P-values - should it be this simple?Interpreting effectsNetwork meta-analyses